Artificial Intelligence (AI) in Precision Medicine Market - Size, Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

Artificial Intelligence (AI) in Precision Medicine Market Overview

Artificial Intelligence (AI) in precision medicine enables personalized healthcare by analyzing patient-specific data, supporting biomarker-based treatment, drug response prediction, and molecular profiling. It facilitates patient stratification, multi-omics integration, and predictive analytics, improving treatment outcomes and reducing adverse effects. The market reached a value of approximately USD 2.21 Billion in 2025, with growth driven by the integration of advanced analytics with genomics and clinical data to enhance patient outcomes and operational efficiency. Key developments include improved clinical decision support, growing use of predictive models, and expanding applications in drug discovery, diagnostics, and personalized treatment planning, supported by strong industry collaborations and technological progress.

Artificial Intelligence (AI) in Precision Medicine Market Growth Drivers

Increasing AI Investment to Accelerate Precision Medicine Innovation and the Market Value

The rising demand for personalized healthcare and greater data availability are driving investments in AI for precision medicine. For instance, in March 2026, Verily Health secured a USD 300 million funding round led by Series X Capital with continued support from Alphabet and healthcare partners, accelerating its AI-native precision health platform. This infusion will enhance data integration, predictive insights, and tailored interventions, driving market expansion during the forecast period.

Artificial Intelligence (AI) in Precision Medicine Market Trends

Key trends shaping the market include AI-driven precision medicine and care.

Growing AI Driven Precision Care Platforms is Likely to Boost the Market Landscape

The growing integration of clinical data and patient engagement AI is shaping precision medicine delivery. For instance, in November 2025, Get Well and RhythmX AI merged to form GW RhythmX, an AI driven precision care platform uniting patient engagement with predictive analytics and clinical insights. This development enables real time personalized treatment recommendations and operational efficiencies, supporting broader adoption of precision medicine technologies.

Artificial Intelligence (AI) in Precision Medicine Market Segmentation

Artificial Intelligence (AI) in Precision Medicine Market Share

Oncology Anticipated to Dominate the Market Segment by Therapeutic Application

The market is segmented into oncology, neurology, cardiology, respiratory, and others, based on the therapeutic application. Among these, oncology led the market, recording a substantial revenue share of around 30% during the historical period. This dominance is driven by the increasing adoption of AI for biomarker-based treatment, predictive modeling, and drug response prediction in cancer care. According to the World Health Organization, global cancer cases are projected to exceed 35 million by 2050, marking a 77% increase from approximately 20 million cases in 2022. AI-powered tools enable patient stratification and personalized therapy planning, enhancing treatment outcomes and accelerating clinical decision supportin oncology globally.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Artificial Intelligence (AI) in Precision Medicine Market Analysis by Region

North America dominated the market during the historical period, accounting for the largest revenue share of above 29%. The region’s leadership is attributed to advanced healthcare infrastructure, strong presence of major pharmaceutical and technology companies, and early adoption of AI-driven platforms. Investments in AI for molecular profiling, multi-omics integration, and personalized therapy have further strengthened North America’s market position and growth trajectory.

Leading Players in the Artificial Intelligence (AI) in Precision Medicine Market

Other key players in the market are Microsoft Corporation, Alphabet Inc., IBM Corporation, Enlitic Inc., AstraZeneca, and Sanofi.

Key Questions Answered in the Artificial Intelligence (AI) in Precision Medicine Market

• What was the artificial intelligence (AI) in precision medicine market value in 2025?
• What is the artificial intelligence (AI) in precision medicine market forecast outlook for 2026-2035?
• What major factors aid the demand for artificial intelligence (AI) in precision medicine market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major artificial intelligence (AI) in precision medicine market trends?
• Which type is expected to dominate the market segment?
• Which components is projected to lead the market segment?
• Which therapeutic area is projected to lead the market segment?
• Who are the key players in the artificial intelligence (AI) in precision medicine market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?